Transfer of Responsibilities. 3.1 In order to achieve compliance under regulations at 21 CFR 312.52, Corcept must identify all responsibilities that will be transferred to Scirex in each Project Exhibit. Each Exhibit will contain a detailed description of transferred obligations. Corcept agrees that the same description and extent of obligations transferred should be included in form ▇▇▇-▇▇▇▇, ▇▇▇▇▇▇▇ #▇▇ relating to the specific Study Drug(s) under investigation. Scirex agrees to carry out diligently all transferred obligations.
Appears in 2 contracts
Sources: Master Clinical Development Agreement (Corcept Therapeutics Inc), Clinical Development Agreement (Corcept Therapeutics Inc)